| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | 7,9 M € | -4.5% | 8,2 M € | -6.1% | 8,8 M € | -9.7% | 9,7 M € | -5.8% | 10,3 M € | -7.6% | 11,1 M € | +5.2% | 10,6 M € | +4.1% | 10,2 M € | +0.8% | 10,1 M € | +4.8% | 9,6 M € | +7.8% | 8,9 M € | |||||||||
| Gross margin | -237,6 k € | -12.8% | -210,7 k € | -115.7% | 1,3 M € | -6.0% | 1,4 M € | +0.3% | 1,4 M € | -6.9% | 1,5 M € | -4.4% | 1,6 M € | +11.6% | 1,4 M € | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||
| EBITDA | -242,7 k € | +77.9% | -1,1 M € | -7332.3% | 15,2 k € | -94.1% | 256,5 k € | -4.4% | 268,1 k € | -29.2% | 378,5 k € | -15.8% | 449,5 k € | +47.5% | 304,7 k € | -15.0% | 358,5 k € | -60.0% | 896,6 k € | +46.2% | 613,3 k € | -12.9% | 703,8 k € | -7.6% | 762,0 k € | -39.7% | 1,3 M € | +27.3% | 992,7 k € | +33.3% | 745,0 k € | -25.4% | 998,5 k € | -7.4% | 1,1 M € | +56.2% | 690,3 k € | |
| Operating profit | -241,4 k € | +78.0% | -1,1 M € | -3616.8% | -29,6 k € | -113.6% | 217,8 k € | -3.9% | 226,7 k € | +42.9% | 158,6 k € | -39.7% | 263,1 k € | +98.7% | 132,4 k € | -32.5% | 196,2 k € | -72.5% | 712,6 k € | +72.3% | 413,6 k € | -11.2% | 465,7 k € | -16.6% | 558,2 k € | -47.3% | 1,1 M € | +36.3% | 776,9 k € | +48.3% | 524,1 k € | -35.0% | 806,7 k € | -3.5% | 836,0 k € | +62.4% | 514,8 k € | |
| Profit/loss | -90,8 k € | +91.5% | -1,1 M € | -20540.8% | 5,2 k € | -98.1% | 273,2 k € | +5.5% | 259,0 k € | +45.5% | 178,0 k € | -32.9% | 265,4 k € | +67.2% | 158,7 k € | -26.7% | 216,5 k € | -67.2% | 659,2 k € | +64.7% | 400,3 k € | -4.0% | 417,0 k € | -14.6% | 488,4 k € | -48.6% | 950,6 k € | +35.5% | 701,5 k € | +55.3% | 451,7 k € | -35.5% | 700,2 k € | -2.3% | 716,3 k € | +62.7% | 440,4 k € | |
| Equity | 896,0 k € | -39.7% | 1,5 M € | -75.0% | 6,0 M € | +0.1% | 6,0 M € | +4.8% | 5,7 M € | -30.8% | 8,2 M € | +2.2% | 8,0 M € | -2.3% | 8,2 M € | +2.0% | 8,1 M € | +2.7% | 7,8 M € | +5.1% | 7,5 M € | +5.7% | 7,1 M € | +0.2% | 7,1 M € | +1.3% | 7,0 M € | +6.9% | 6,5 M € | +6.6% | 6,1 M € | +5.7% | 5,8 M € | +10.2% | 5,2 M € | +10.4% | 4,8 M € | |
| Total assets | 910,9 k € | -44.8% | 1,6 M € | -75.5% | 6,7 M € | +1.5% | 6,6 M € | +1.3% | 6,5 M € | -25.1% | 8,7 M € | -2.9% | 9,0 M € | -0.2% | 9,0 M € | -0.7% | 9,1 M € | +0.9% | 9,0 M € | +4.3% | 8,6 M € | +2.6% | 8,4 M € | -11.6% | 9,5 M € | +0.7% | 9,5 M € | +9.0% | 8,7 M € | +4.0% | 8,3 M € | -4.6% | 8,7 M € | +13.5% | 7,7 M € | +5.6% | 7,3 M € | |
| Cash | 668,2 k € | +29.2% | 517,4 k € | -19.2% | 640,3 k € | +110.4% | 304,3 k € | -75.6% | 1,2 M € | +13.8% | 1,1 M € | +2.6% | 1,1 M € | +19.0% | 897,2 k € | -44.9% | 1,6 M € | +39.7% | 1,2 M € | -14.3% | 1,4 M € | +1.1% | 1,3 M € | +55.1% | 867,6 k € | +0.1% | 866,7 k € | +35.9% | 637,7 k € | +200.1% | 212,5 k € | -73.9% | 815,0 k € | +32.9% | 613,0 k € | +90.5% | 321,7 k € | |
| Debts | 15,0 k € | -90.8% | 162,8 k € | -78.9% | 772,0 k € | +13.9% | 678,1 k € | -21.0% | 857,8 k € | +66.9% | 514,0 k € | -45.9% | 949,8 k € | +21.4% | 782,6 k € | -22.3% | 1,0 M € | -11.6% | 1,1 M € | -0.2% | 1,1 M € | -12.5% | 1,3 M € | -46.3% | 2,4 M € | -1.0% | 2,5 M € | +16.0% | 2,1 M € | -3.2% | 2,2 M € | -25.1% | 2,9 M € | +20.8% | 2,4 M € | -3.6% | 2,5 M € | |
| Staff | 0 | 10,3 | 12,6 | 12,4 | 13,1 | 12,7 | 13,3 | 13,9 | 13,4 | 12,8 | 13,9 | 15,2 | 15,4 | 15,7 | 16,2 | 16 | 16 | 17,2 | 16,3 | |||||||||||||||||||
Public limited company · Ninove · incorporated on 15/10/1985 · 0,0 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+29.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Paepens is a Public limited company incorporated in 1985. Its main activity is: Management consultancy activities. Its registered office is in Ninove.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette